The proliferation of HRAS-mutant cancer cell lines Hs 578 T (Fig. 6a, e) and T24 (Fig. 6b, e) was specifically reduced by TAT-L5URcore, but not the control TAT-peptides. Here, HRAS is linked to cancer.